Let’s be perfectly clear - AIDS is big business. And don’t let’s be naive - I’m sure there are research and science issues to overcome, but ultimately, I’ll eat my laptop if the lack of a cure or vaccine for HIV has nothing to do with the fact that curing someone is a lot less profitable than making someone dependent for life on the little pills that only you can make.
In today’s global economy, the study, control, and treatment of any world health problem as widespread as HIV/AIDS is completely inseparable from hegemonic power interests, and from the fact that over the last 20 years people with brown and black skin have become the majority of those dying of AIDS. And here I do not hesitate to point an accusing finger at my fellow homosexuals, who even today write songs and novels about the dark days of the epidemic when we reached out for succor and the entire world turned its face from us. Funny how many white gay men remain bitter over that historical tragedy while ignoring the fact that entire nations are being ravaged by the very same virus today.
Just to put things in perspective, in 2012 the US National Institutes of Health spent $3,075 million dollars on HIV/AIDS research…and $3,737 million on the study of “rare diseases.” Uh…shouldn’t we maybe focus on curing the really fucking common ones first? For that matter, the NIH spent $2,562 million on research related to aging. You know why? Because the baby boomers that run the place are getting old.
So yes. News like this makes me happy, because history has repeatedly shown that scientific problems get solved more quickly and efficiently when they are tackled in simultaneously in multiple places from multiple perspectives - and preferably without the lobbying pressure of the United States pharmaceutical companies.